Pregnancy Clinical Trial
Official title:
Early Prevention of Childhood Obesity: an Active Pregnancy
The main aim of this study was to examine the effect of a supervised physical exercise program on the prevention of childhood obesity and its impact on the motor development of the offspring.
| Status | Recruiting |
| Enrollment | 1100 |
| Est. completion date | April 2018 |
| Est. primary completion date | August 2014 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Female |
| Age group | 18 Years to 45 Years |
| Eligibility |
Inclusion Criteria: - Being healthy and able to exercise following American College of Obstetricians and Gynecologists (ACOG) guidelines - Being able to communicate in spanish - Giving birth at Hospital Universitario de Torrejón, hospital Universitario de Puerta de Hierro and Hospital Universitario Severo Ochoa (Madrid). Exclusion Criteria: - Multiparity - Obstetrician complications - Being interested in the study after 16 weeks - Not being regular in physical exercise program - Younger than 18 years old |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Prevention
| Country | Name | City | State |
|---|---|---|---|
| Spain | Universidad Politécnica de Madrid | Madrid |
| Lead Sponsor | Collaborator |
|---|---|
| Technical University of Madrid |
Spain,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Body mass index of the offsprings | Body mass index was measured several times from 0 to 24 months | 0-24 postpartum months | No |
| Primary | Fetus body composition | Fetus body composition (percentage of fat) was measured several times from 0 to 24 months | 0-24 postpartum months | No |
| Primary | Change from baseline in Maternal gestational weight gain | Maternal weight gain during pregnancy | 40-42 weeks of gestation | No |
| Primary | Changes in Baby motor development | Baby motor development was measured after delivery | 0-24 postpartum months | No |
| Primary | Recovery time to pre-gestational weight | The time needed to recovery the pre-gestational weight was assessed. | 6-12 postpartum months | No |
| Primary | Glycemia level of the offsprings | Glycemia level of the offsprings was measured until 24 months | 0-24 postpartum months | No |
| Primary | Postpartum depression | The level of maternal depression was measured after delivery | 0-12 postpartum months | No |
| Primary | Change from baseline in Body image satisfaction | Body image satisfaction was measured during and after pregnancy | up to 36 weeks | No |
| Primary | Changes from baseline in maternal quality of life | Maternal quality of life was measured during and after pregnancy | up to 36 weeks | No |
| Primary | Placenta measurements | Placenta measurements were collected at labor | At delivery | No |
| Secondary | Maternal outcomes | Type of labor, stage of labor and some other maternal variables were measured at delivery | At delivery | Yes |
| Secondary | Control of physical activity | Control the level of physical activity during and after pregnancy | up to 10 weeks | No |
| Secondary | Changes from delivery in Health of the offspring | Health of the baby included the measurement of other variables such as blood pressure and cholesterol of the offsprings until 24 months | 0-24 postpartum months | No |
| Secondary | Fetus outcomes | Fetus outcomes were measured at delivery: Apgar score, PH umbilical cord, size and height of the baby, head circumference | At delivery | Yes |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
| Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
| Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
| Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
| Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
| Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
| Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
| Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
| Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
| Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
| Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
| Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
| Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
| Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
| Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
| Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
| Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
| Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
| Completed |
NCT02408315 -
Induction With Misoprostol: Oral Mucosa Versus Vaginal Epithelium (IMPROVE)
|
Phase 3 |